Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact Us
Early Edition  //  Current Issue  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited

Medicine Research ›› 2020, Vol. 4 ›› Issue (1-2): 200007-200007.DOI: 10.21127/yaoyimr20200007

• Reports • Previous Articles     Next Articles

Augmented Reality in Drug Package: a Promising Strategy against Non-adherence in the Treatment of Tuberculosis

Dayse E. de Oliveira, Marcus V. N. de Souza,* and Wanise B. G. Barroso   

  1. Fundação Oswaldo Cruz (Fiocruz), Instituto de Tecnologia em Fármacos (Farmanguinhos), Rua Sizenando Nabuco, 100, Manguinhos, 21041-250 Rio de Janeiro, Brazil
  • Received:2020-04-07 Revised:2020-04-18 Online:2020-06-10 Published:2020-06-16
  • Contact: mvndesouza@gmail.com (M. V. N. S.)
  • Supported by:

Abstract: Augmented reality is a technology-based on an interaction between the virtual and real-world, mixing them and expanding their possibilities. This technology is currently used in the most varied areas of human knowledge. The use of augmented reality in drug package has excellent potential in several diseases and could be an indispensable tool, especially in diseases with low medication adherence. In this context, its application in tuberculosis treatment could be of great help, as this treatment presents two major issues: the long-term treatment time (six months) and its severe side effects resulting in its non-adherence to the treatment. In this article, we aim to address the problems related to tuberculosis treatment causing non-adherence by using augmented reality. Using a smartphone in the medicine packaging could gain valuable information making patients be aware of following the treatment until the end.


Key words: augmented reality, tuberculosis, non-adherence treatment

Copyright © Medicine Research, All Rights Reserved.
Address: 425 East 76th Street, Apt 9E, New York, NY, 10021, United States